TARS vs TSM Stock Comparison
TSM currently leads TARS in this stock comparison, with AIQ scores of 67 vs 65. The clearest difference is quality, while TARS has the stronger momentum profile.
What is the main difference between TARS and TSM?
TSM leads the current stock comparison as Taiwan Semiconductor Manufacturing Company Limited, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Tarsus Pharmaceuticals, Inc. vs Taiwan Semiconductor Manufacturing Company Limited
TSM leads
TSM leads by 2 AIQ points, primarily on Quality.
Fragile: 2 of 6 evidence groups support TSM, and its current signal state is conflicted.
Tarsus Pharmaceuticals, Inc.
Taiwan Semiconductor Manufacturing Company Limited
The Algovestiq AIQ Score currently favors TSM over TARS, 67 versus 65 as of Nov 15, 2026. TSM's advantage is driven primarily by stronger quality, while TARS holds the stronger momentum profile. TSM also shows the weaker technical structure relative to its 50-day moving average. 2 of 6 covered evidence groups favor TSM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 2 points. TSM lead: Stable — the AIQ differential has held near 2 points over 30 sessions.
Compare Tarsus Pharmaceuticals, Inc. and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare TARS and TSM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality50 vs 74TSM +24
- Momentum76 vs 66TARS +10
- Value75 vs 66TARS +9
- Risk Resilience59 vs 58Even
2 of 6 evidence groups favor TSM. TSM’s edge is concentrated in quality; TARS keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +2
New signals
- BB Upper Band Breach — bearish, volatility, short horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
Largest factor move: Momentum +2, not enough on its own to move the overall score.
New signals
- Price Lost 200-Day MA — bearish, trend, long horizon
TSM's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — TARS and TSM both carry a full feed there.
The central trade-off
TSM (Taiwan Semiconductor Manufacturing Company Limited): the stronger current systematic profile, led by quality.
TARS (Tarsus Pharmaceuticals, Inc.): the counter-case, on momentum, value, valuation.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TSMTSM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
TSMTSM on combined revenue and EPS growth.
Value
TARSTARS on the peer-relative Value factor, by 9 points.
Momentum
TARSTARS on the Momentum factor, by 10 points.
Lower downside
TARSTARS carries the lower 1-month annualized volatility.
Analyst upside
TSMTSM on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | TARS | TSM | Note |
|---|---|---|---|
| Implied upside to target | +36.1% | +44.5% | TSM has more room |
| Target dispersion | +10.1% | +26.9% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 10 | 22 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
2 of 6 covered evidence groups favor TSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | Even | 65 vs 67 |
| Fundamentals | TSMon balance | revenue growth 11.9% vs 17.6%; EPS growth -32.5% vs 8%; TTM ROE -6.4% vs 10.9%; gross margin 93.2% vs 65.8%; operating margin -102% vs 57.9% — TSM takes 4 of 5 decided legs, not all of them |
| Valuation | TARS | Value 75 vs 66 |
| Technicals | TARS | Price vs 50-day 7.3% vs -7.3%; vs 200-day 18.1% vs -1.1% |
| Risk Resilience | Even | Risk Resilience 59 vs 58 |
| Analyst expectations | TSM | Target upside 36.1% vs 44.5% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of TARS and TSM and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is narrow at 2 points. (argues the conclusion is provisional)
- Only 2 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TSM.
How the comparison changed
120 daily snapshots · May 27 – Nov 13TSM lead: Stable — the AIQ differential has held near 2 points over 30 sessions.
- Today
- TSM +2
- 65 vs 67
- 7 sessions ago
- TSM +2
- 66 vs 68
- 30 sessions ago
- TSM +2
- 70 vs 72
- 90 sessions ago
- TSM +2
- 66 vs 68
The lead changed hands 3 times in this window, most recently on Nov 6 when TSM moved ahead of TARS.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
5 bullish / 1 bearish / 1 neutral, conflicted
Only TARS
- BB Upper Band Breach — bearish, volatility, short horizon
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- Uptrend Structure Active — bullish, trend, long horizon
2 bullish / 2 bearish / 1 neutral, conflicted
Only TSM
- Price Lost 200-Day MA — bearish, trend, long horizon
- Beta Spike Warning — bearish, risk_regime, long horizon
Both carry 3 more signals that do not separate them: Golden Cross Active, ATR Expansion - Breakout Mode, MACD Histogram Expanding Bullish.
TSM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved up over the latest session (price +4.41%, AIQ +1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.67%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1TARS closes the Quality gap — currently 24 points behind, the largest single contributor to TSM's edge.
- 2TARS's BB Upper Band Breach resolves — a bearish volatility rule currently active against it.
- 3TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
TSM leads on balance| Metric | TARS | TSM |
|---|---|---|
| Revenue growth (YoY) | 11.9% | 17.6% |
| EPS growth (YoY) | -32.5% | 8% |
| Gross margin | 93.2% | 65.8% |
| Operating margin | -102% | 57.9% |
| Return on equity (TTM) | -6.4% | 10.9% |
| Debt to equity | 0.85 | 0.14 |
Performance
TARS leads 4 of 6 windows| Metric | TARS | TSM |
|---|---|---|
| 1 week (5 sessions) | 17% | 6.2% |
| 1 month (20 sessions) | 17.9% | -3.4% |
| 3 months (63 sessions) | 13.7% | -7.5% |
| 6 months (126 sessions) | 28.5% | -1.4% |
| Year to date | -2% | 31.2% |
| 1 year (252 sessions) | 7.3% | 37.2% |
Technicals
TARS has the stronger structure| Metric | TARS | TSM |
|---|---|---|
| RSI (14) | 64.8 | 45.3 |
| ADX (14) | 16.7 | 29.2 |
| Price vs 50-day | 7.3% | -7.3% |
| Price vs 200-day | 18.1% | -1.1% |
| Volatility (1M, annualized) | 44.7% | 61.7% |
Risk
Split| Metric | TARS | TSM |
|---|---|---|
| Beta | 0.56 | 2.16 |
| Sharpe ratio | 0.36 | 0.95 |
| Sortino ratio | 0.55 | 1.37 |
| Max drawdown | -32% | -27.3% |
| Current drawdown | -11.6% | -17.9% |
| Annualized volatility | 45% | 41.8% |
| Value at risk (95%) | -4.2% | -4.2% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, TARS or TSM?
On the Algovestiq AIQ Score, TSM is the stronger of the two as of Nov 15, 2026, scoring 67 against TARS's 65. The edge comes from quality. TARS is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is TARS or TSM the better buy right now?
TSM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 2 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 2 points. Treat the lead as provisional.
Why does the AIQ Score favor TSM over TARS?
The composite weights Quality, Value, Momentum and Risk Resilience. TSM leads Quality by 24 points; TARS leads Momentum by 10 points; TARS leads Value by 9 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, TARS or TSM?
Analyst price targets imply +36.1% upside for TARS and +44.5% for TSM, so the Street currently favors TSM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, TARS or TSM?
TARS is the better-valued of the two on the peer-relative Value factor. TARS on the peer-relative Value factor, by 9 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, TARS or TSM?
TSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, TARS or TSM?
TARS on the Momentum factor, by 10 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, TARS or TSM?
TARS is the more resilient of the two, so the other name carries the higher downside risk. TARS carries the lower 1-month annualized volatility. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is TARS more profitable than TSM?
The profitability evidence is mixed: gross margin 93.2% vs 65.8%; operating margin -102% vs 57.9%; ttm roe -6.4% vs 10.9%. TARS leads on one measure and TSM on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is TSM's lead over TARS getting stronger or weaker?
TSM lead: Stable — the AIQ differential has held near 2 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 3 times in that window, most recently on 2026-11-06, when TSM moved ahead of TARS.
What would change the TARS vs TSM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: TARS closes the Quality gap — currently 24 points behind, the largest single contributor to TSM's edge; TARS's BB Upper Band Breach resolves — a bearish volatility rule currently active against it; TSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about TARS and TSM?
TARS: 5 bullish / 1 bearish / 1 neutral, conflicted. TSM: 2 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on TARS is Golden Cross Active (bullish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).
Compare TARS and TSM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.